Aveanna Healthcare (AVAH) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

AVAH Stock Forecast


Aveanna Healthcare stock forecast is as follows: an average price target of $4.10 (represents a -28.94% downside from AVAH’s last price of $5.77) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.

AVAH Price Target


The average price target for Aveanna Healthcare (AVAH) is $4.10 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $2.00. This represents a potential -28.94% downside from AVAH's last price of $5.77.

AVAH Analyst Ratings


Buy

According to 5 Wall Street analysts, Aveanna Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for AVAH stock is 1 'Strong Buy' (20.00%), 2 'Buy' (40.00%), 2 'Hold' (40.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Aveanna Healthcare Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 09, 2024Ben HendrixRBC Capital$5.00$4.872.67%-13.34%
Nov 17, 2022-Credit Suisse$2.00$0.80149.25%-65.34%
Aug 19, 2022-Barclays$5.00$2.13134.74%-13.34%
Aug 15, 2022-Raymond James$6.00$2.14180.37%3.99%
Jul 12, 2022David MacDonaldTruist Financial$2.50$2.490.40%-56.67%
Row per page
Go to

The latest Aveanna Healthcare stock forecast, released on Aug 09, 2024 by Ben Hendrix from RBC Capital, set a price target of $5.00, which represents a 2.67% increase from the stock price at the time of the forecast ($4.87), and a -13.34% decrease from AVAH last price ($5.77).

Aveanna Healthcare Price Target by Period


1M3M12M
# Anlaysts--1
Avg Price Target--$5.00
Last Closing Price$5.77$5.77$5.77
Upside/Downside-100.00%-100.00%-13.34%

In the current month, the average price target of Aveanna Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Aveanna Healthcare's last price of $5.77. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 09, 2024Deutsche BankBuyBuyHold
Aug 09, 2024RBC CapitalSector PerformSector PerformHold
Nov 17, 2022Credit Suisse-NeutralDowngrade
Nov 16, 2022Raymond JamesStrong BuyStrong BuyHold
Aug 19, 2022BarclaysOverweightOverweightHold
Aug 15, 2022Raymond JamesStrong BuyStrong BuyHold
Row per page
Go to

Aveanna Healthcare's last stock rating was published by Deutsche Bank on Aug 09, 2024. The company gave AVAH a "Buy" rating, the same as its previous rate.

Aveanna Healthcare Financial Forecast


Aveanna Healthcare Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Revenue--------------$471.94M$466.41M$451.15M$443.01M$442.95M$450.53M-$411.28M$436.11M$417.16M
Avg Forecast$569.90M$561.00M$564.30M$543.90M$527.85M$532.83M$530.31M$516.24M$499.80M$495.87M$493.49M$483.98M$464.99M$453.69M$457.57M$452.03M$448.16M$446.78M$450.62M$434.33M$417.33M$445.79M$434.01M$414.39M
High Forecast$572.73M$563.78M$567.10M$546.60M$530.47M$535.48M$532.94M$517.96M$501.26M$495.99M$493.49M$484.00M$474.33M$453.69M$459.85M$454.27M$450.38M$446.78M$450.62M$434.33M$417.33M$445.79M$434.01M$414.39M
Low Forecast$566.18M$557.34M$560.62M$540.35M$524.41M$529.36M$526.85M$515.01M$496.21M$495.74M$493.49M$483.95M$459.36M$453.69M$454.59M$449.08M$445.23M$446.78M$450.62M$434.33M$417.33M$445.79M$434.01M$414.39M
# Analysts222211155255633323333333
Surprise %--------------1.03%1.03%1.01%0.99%0.98%1.04%-0.92%1.00%1.01%

Aveanna Healthcare's average Quarter revenue forecast for Sep 23 based on 3 analysts is $453.69M, with a low forecast of $453.69M, and a high forecast of $453.69M. AVAH's average Quarter revenue forecast represents a -3.87% decrease compared to the company's last Quarter revenue of $471.94M (Jun 23).

Aveanna Healthcare EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts222211155255633323333333
EBITDA-------------$-102.39M$-8.09M$24.37M$7.56M$14.29M$24.27M$22.48M-$20.07M$31.57M$36.93M
Avg Forecast$-25.61M$-25.21M$-25.36M$-24.44M$-23.72M$-23.94M$-23.83M$-23.20M$-22.46M$-22.28M$-22.18M$42.13M$-20.90M$-20.39M$-20.56M$38.30M$10.97K$28.40M$28.64M$34.82M$26.53M$28.34M$27.59M$31.65M
High Forecast$-25.44M$-25.05M$-25.19M$-24.28M$-23.57M$-23.79M$-23.68M$-23.14M$-22.30M$-22.28M$-22.18M$50.56M$-20.64M$-20.39M$-20.43M$45.96M$13.17K$28.40M$28.64M$41.78M$26.53M$28.34M$27.59M$37.99M
Low Forecast$-25.74M$-25.33M$-25.48M$-24.56M$-23.84M$-24.06M$-23.95M$-23.28M$-22.53M$-22.29M$-22.18M$33.71M$-21.32M$-20.39M$-20.66M$30.64M$8.78K$28.40M$28.64M$27.86M$26.53M$28.34M$27.59M$25.32M
Surprise %-------------5.02%0.39%0.64%689.15%0.50%0.85%0.65%-0.71%1.14%1.17%

3 analysts predict AVAH's average Quarter EBITDA for Jun 23 to be $-20.56M, with a high of $-20.43M and a low of $-20.66M. This is -184.36% lower than Aveanna Healthcare's previous annual EBITDA (Mar 23) of $24.37M.

Aveanna Healthcare Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts222211155255633323333333
Net Income-------------$-102.39M$25.60M$-32.00M$-237.78M$24.30M$-473.89M$25.33M-$2.09M$1.26M$5.80M
Avg Forecast$13.54M$11.60M$11.60M$11.60M$5.68M$5.55M$6.01M$1.48M$88.75K$-2.42M$-3.96M$6.61M$-4.82M$-4.22M$-7.06M$6.01M$-4.12M$7.25M$11.51M$5.47M$21.94M$23.23M$19.98M$4.97M
High Forecast$13.62M$11.68M$11.68M$11.68M$5.71M$5.58M$6.05M$11.32M$2.11M$-2.40M$-3.92M$7.94M$-2.41M$-4.18M$-7.00M$7.22M$-4.09M$7.25M$11.51M$6.56M$21.94M$23.23M$19.98M$5.96M
Low Forecast$13.42M$11.50M$11.50M$11.50M$5.63M$5.50M$5.96M$-4.13M$-2.11M$-2.43M$-3.98M$5.29M$-7.23M$-4.24M$-7.11M$4.81M$-4.15M$7.25M$11.51M$4.37M$21.94M$23.23M$19.98M$3.98M
Surprise %-------------24.28%-3.63%-5.32%57.67%3.35%-41.17%4.63%-0.09%0.06%1.17%

Aveanna Healthcare's average Quarter net income forecast for Sep 23 is $-4.22M, with a range of $-4.24M to $-4.18M. AVAH's average Quarter net income forecast represents a -116.48% decrease compared to the company's last Quarter net income of $25.60M (Jun 23).

Aveanna Healthcare SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts222211155255633323333333
SG&A---------------$60.77M$110.68M$122.76M$125.20M$125.31M-$114.24M$110.12M$96.77M
Avg Forecast$143.50M$141.25M$142.09M$136.95M$132.91M$134.16M$133.53M$129.98M$125.84M$124.85M$124.26M$110.40M$117.08M$114.24M$115.21M$100.37M$112.84M$112.50M$113.46M$91.24M$105.08M$112.25M$109.28M$82.95M
High Forecast$144.21M$141.96M$142.79M$137.63M$133.57M$134.83M$134.19M$130.42M$126.21M$124.88M$124.26M$132.48M$119.43M$114.24M$115.78M$120.44M$113.40M$112.50M$113.46M$109.49M$105.08M$112.25M$109.28M$99.54M
Low Forecast$142.56M$140.33M$141.16M$136.06M$132.04M$133.29M$132.66M$129.67M$124.94M$124.82M$124.26M$88.32M$115.66M$114.24M$114.46M$80.29M$112.11M$112.50M$113.46M$72.99M$105.08M$112.25M$109.28M$66.36M
Surprise %---------------0.61%0.98%1.09%1.10%1.37%-1.02%1.01%1.17%

Aveanna Healthcare's average Quarter SG&A projection for Jun 23 is $115.21M, based on 3 Wall Street analysts, with a range of $114.46M to $115.78M. The forecast indicates a 89.58% rise compared to AVAH last annual SG&A of $60.77M (Mar 23).

Aveanna Healthcare EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
# Analysts222211155255633323333333
EPS-------------$-0.54$0.14$-0.17$-1.28$0.13$-2.56$0.14-$0.01$0.01$0.03
Avg Forecast$0.07$0.06$0.06$0.06$0.03$0.03$0.03$0.01-$-0.01$-0.02$-0.05$-0.02$-0.02$-0.04$-0.06$-0.02$0.04$0.06$0.06$0.11$0.12$0.10$0.07
High Forecast$0.07$0.06$0.06$0.06$0.03$0.03$0.03$0.06$0.01$-0.01$-0.02$-0.05$-0.01$-0.02$-0.04$-0.06$-0.02$0.04$0.06$0.06$0.11$0.12$0.10$0.07
Low Forecast$0.07$0.06$0.06$0.06$0.03$0.03$0.03$-0.02$-0.01$-0.01$-0.02$-0.05$-0.04$-0.02$-0.04$-0.06$-0.02$0.04$0.06$0.06$0.11$0.12$0.10$0.07
Surprise %-------------24.76%-3.83%2.82%60.03%3.53%-43.78%2.33%-0.08%0.07%0.44%

According to 3 Wall Street analysts, Aveanna Healthcare's projected average Quarter EPS for Sep 23 is $-0.02, with a low estimate of $-0.02 and a high estimate of $-0.02. This represents a -115.58% decrease compared to AVAH previous annual EPS of $0.14 (Jun 23).

Aveanna Healthcare Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ACHCAcadia Healthcare Company$39.10$82.33110.56%Buy
SGRYSurgery Partners$22.51$40.8081.25%Buy
INNVInnovAge$4.70$6.8044.68%Hold
BKDBrookdale Senior Living$5.22$7.5043.68%Buy
EHABEnhabit$7.46$10.2537.40%Hold
OPCHOption Care Health$21.88$29.5034.83%Buy
PNTGPennant Group$30.78$34.6712.64%Buy
ADUSAddus HomeCare$120.99$132.809.76%Buy
UHSUniversal Health Services$197.52$208.475.54%Hold
SEMSelect Medical$38.09$40.005.01%Buy
ENSGEnsign Group$144.66$148.202.45%Buy
EHCEncompass Health$98.93$97.00-1.95%Buy
AVAHAveanna Healthcare$5.77$4.10-28.94%Buy

AVAH Forecast FAQ


Is Aveanna Healthcare a good buy?

Yes, according to 5 Wall Street analysts, Aveanna Healthcare (AVAH) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 2 'Buy' recommendations, accounting for 60.00% of AVAH's total ratings.

What is AVAH's price target?

Aveanna Healthcare (AVAH) average price target is $4.1 with a range of $2 to $6, implying a -28.94% from its last price of $5.77. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Aveanna Healthcare stock go up soon?

According to Wall Street analysts' prediction for AVAH stock, the company can go down by -28.94% (from the last price of $5.77 to the average price target of $4.1), up by 3.99% based on the highest stock price target, and down by -65.34% based on the lowest stock price target.

Can Aveanna Healthcare stock reach $9?

AVAH's average twelve months analyst stock price target of $4.1 does not support the claim that Aveanna Healthcare can reach $9 in the near future.

What are Aveanna Healthcare's analysts' financial forecasts?

Aveanna Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.11B (high $2.12B, low $2.1B), average EBITDA is $-94.693M (high $-94.171M, low $-95.125M), average net income is $18.71M (high $28.66M, low $12.96M), average SG&A $530.58M (high $533M, low $527.66M), and average EPS is $0.0968 (high $0.148, low $0.067). AVAH's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.24B (high $2.25B, low $2.22B), average EBITDA is $-101M (high $-99.962M, low $-101M), average net income is $48.34M (high $48.65M, low $47.93M), average SG&A $563.78M (high $566.58M, low $560.11M), and average EPS is $0.25 (high $0.252, low $0.248).

Did the AVAH's actual financial results beat the analysts' financial forecasts?

Based on Aveanna Healthcare's last annual report (Dec 2023), the company's revenue was $1.9B, beating the average analysts forecast of $1.83B by 3.66%. Apple's EBITDA was $21.85M, missing the average prediction of $-23.543M by -192.81%. The company's net income was $-135M, beating the average estimation of $-10.087M by 1233.66%. Apple's SG&A was $0, missing the average forecast of $446.89M by -100.00%. Lastly, the company's EPS was $0, missing the average prediction of $-0.144 by -100.00%. In terms of the last quarterly report (Jun 2023), Aveanna Healthcare's revenue was $471.94M, beating the average analysts' forecast of $457.57M by 3.14%. The company's EBITDA was $-8.085M, missing the average prediction of $-20.562M by -60.68%. Aveanna Healthcare's net income was $25.6M, missing the average estimation of $-7.061M by -462.52%. The company's SG&A was $0, missing the average forecast of $115.21M by -100.00%. Lastly, the company's EPS was $0.14, missing the average prediction of $-0.0365 by -483.36%